MarketBeatSat, 16 May 2026 19:06:31 GMTErasca Touts 'Eye-Popping' ERAS-0015 Lung Cancer Data, FDA Path at BofA ConferenceERAS+1.12%
Seeking AlphaThu, 14 May 2026 00:50:45 GMTErasca, Inc. (ERAS) Presents at Bank of America Global Healthcare Conference 2026 TranscriptERAS+1.12%
Seeking AlphaMon, 11 May 2026 22:25:30 GMTErasca: 'Hold' On Substantial RAS Targeting ERAS-0015 But With Two Key RisksERAS+1.12%
BarronsTue, 28 Apr 2026 16:29:00 GMTErasca Stock Sinks 50% in Race for ‘Miracle' Cancer Drug. What's Behind the Historic Sell-Off.ERAS+1.12%
BenzingaTue, 28 Apr 2026 13:19:00 GMTWhy Is Cancer Drug Developer Erasca Stock Plunging On Tuesday?ERAS+1.12%
Seeking AlphaTue, 28 Apr 2026 02:51:36 GMTErasca, Inc. (ERAS) Discusses Preliminary Phase I Data and Differentiation of Pan-RAS Molecular Glue ERAS-0015 TranscriptERAS+1.12%
The Motley FoolThu, 26 Mar 2026 21:44:22 GMTErasca CMO's Direct Stake Hit Zero. Her Options Position Didn'tERAS+1.12%
